Enzene Biosciences Ltd.
2 clinical trials · Sponsor
◉ Watch Enzene Biosciences Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Study to Compare Biosimilar Denosumab With Prolia® (NCT05405725) | Enzene Biosciences Ltd. | 2022-07-04 |
| Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers (NCT05245669) | Enzene Biosciences Ltd. | 2022-01-10 |
Track Enzene Biosciences Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.